Platelet-rich plasma for patellar tendinopathy: a randomized controlled trial correlating clinical outcomes and quantitative imaging.

ABSTRACT:

Background

Patellar tendinopathy is a common overuse injury in active individuals, often with incomplete recovery. Recently, platelet-rich plasma (PRP) treatment has shown promising results. Traditional qualitative markers are not reliable indicators of treatment response. Advanced quantitative imaging, such as ultrashort-echo time (UTE) MRI and US shear-wave elastography may be valuable adjuncts.

Purpose

To investigate the clinical outcomes and quantitative imaging changes in adults with symptomatic patellar tendinopathy treated with PRP, needle tenotomy, or sham injection.

Materials and methods

Single-blinded prospective randomized controlled trial from April 2017 until July 2022 with 3 parallel interventions in athletes with symptomatic patellar tendinopathy: PRP,

SUBMITTER: van der Heijden RA 

PROVIDER: S-EPMC12481695 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature